Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a new page build. This reflects a small metadata update rather than changes to the study data or layout.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a new revision label (v3.6.3) replacing the previous v3.6.0, indicating a newer release of the page's documentation.SummaryDifference0.0%

- Check47 days agoChange DetectedRecruitment status is updated to indicate no longer enrolling participants, and new guidance/navigation sections have been added. The label 'Intervention / Treatment' is reformatted to 'Intervention/Treatment' and the revision version updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check54 days agoChange DetectedThe page's Revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the document version.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, representing a small patch to the site build. This change does not introduce visible content or functionality changes.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page’s footer shows an updated revision/version number, indicating a site or interface release. No change to the study details or content sections (e.g., objectives, eligibility, interventions, or outcomes) is implied by this update.SummaryDifference0.0%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.